track | THE "NEW" PROSTATE CANCER INFOLINK

Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of

Prostate Cancer International.
Awards
Other PCI web sites

El Cáncer de Próstata Latinoamérica
Prostate Cancer Africa
Prostate Cancer Caribbean
Solidarité Prostate InfoLink
Copyright © 2008-18 Prostate Cancer International, Inc.

FDA “fast tracks” ARV-110 for the treatment of mCRPC

Posted on June 9, 2019 by Sitemaster

At the end of May, just prior to the annual meeting of ASCO, the US Food and Drug Administration (FDA) granted fast track designation to an investigational agent called ARV-110 for treatment of metastatic, castration-resistant prostate cancer (mCRPC). … -READ MORE …

Filed under: Drugs in development | Tagged: ARV-110, castration-resistant, fast, FDA, mCRPC, metastatic, track | Leave a comment »

THE "NEW" PROSTATE CANCER INFOLINK

A service of

Awards

Other PCI web sites

FDA “fast tracks” ARV-110 for the treatment of mCRPC

Disclaimer

Hot Posts …

… and Archives